Pages that link to "Q46426001"
Jump to navigation
Jump to search
The following pages link to Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain (Q46426001):
Displaying 26 items.
- Bupropion induced serotonin syndrome: a case report (Q24631553) (← links)
- Mechanistic insights into nicotine withdrawal (Q27687645) (← links)
- Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine. (Q34060576) (← links)
- Neurocognitive predictors of antidepressant clinical response (Q35899165) (← links)
- Acute systemic infusion of bupropion decrease formalin induced pain behavior in rat. (Q37709123) (← links)
- Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder (Q37734565) (← links)
- Rational site-directed pharmacotherapy for major depressive disorder (Q38112732) (← links)
- Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum (Q41816897) (← links)
- Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain (Q42592621) (← links)
- Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation (Q42732579) (← links)
- The well of novel antidepressants: running dry. (Q42739872) (← links)
- Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. (Q43105503) (← links)
- Restoration of serotonin neuronal firing following long-term administration of bupropion but not paroxetine in olfactory bulbectomized rats. (Q43186658) (← links)
- A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment (Q43219790) (← links)
- Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons (Q43235418) (← links)
- Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging. (Q44644323) (← links)
- Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. (Q45973903) (← links)
- Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation (Q47644422) (← links)
- Modulation of attention network activation under antidepressant agents in healthy subjects (Q47937723) (← links)
- Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. (Q48691574) (← links)
- Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion (Q48886008) (← links)
- An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments? (Q48908106) (← links)
- General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry (Q51509688) (← links)
- In Response to Borgsteede et al. About Bupropion and Serotonin Toxicity (Q89994148) (← links)
- A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures (Q90139105) (← links)
- In vivo electrophysiological recordings of the effects of antidepressant drugs (Q91953187) (← links)